Kevin Yee

Assistant Professor

  • 1228 Citations
  • 8 h-Index
20022009

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1228 Citations
  • 8 h-Index
  • 7 Article
  • 1 Review article
Filter
Article
2009

The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin

Schittenhelm, M. M., Kampa, K. M., Yee, K. W. H. & Heinrich, M. C., Aug 15 2009, In : Cell Cycle. 8, 16, p. 2621-2630 10 p.

Research output: Contribution to journalArticle

Open Access
26 Scopus citations
2006

FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248)

Schittenhelm, M. M., Yee, K. W. H., Tyner, J. W., McGreevey, L., Haley, A. D., Town, A., Griffith, D. J., Bainbridge, T., Braziel, R. M., O'Farrell, A. M., Cherrington, J. M. & Heinrich, M. C., Nov 2006, In : Leukemia. 20, 11, p. 2008-2014 7 p.

Research output: Contribution to journalArticle

30 Scopus citations
2004

Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970

Corbin, A. S., Griswold, I. J., La Rosée, P., Yee, K. W. H., Heinrich, M. C., Reimer, C. L., Druker, B. J. & Deininger, M. W. N., Dec 1 2004, In : Blood. 104, 12, p. 3754-3757 4 p.

Research output: Contribution to journalArticle

66 Scopus citations

Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells

Yee, K. W. H., Schittenhelm, M., O'Farrell, A. M., Town, A. R., McGreevey, L., Bainbridge, T., Cherrington, J. M. & Heinrich, M. C., Dec 15 2004, In : Blood. 104, 13, p. 4202-4209 8 p.

Research output: Contribution to journalArticle

108 Scopus citations
2003

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

O'Farrell, A. M., Abrams, T. J., Yuen, H. A., Ngai, T. J., Louie, S. G., Yee, K. W. H., Wong, L. M., Hong, W., Lee, L. B., Town, A., Smolich, B. D., Manning, W. C., Murray, L. J., Heinrich, M. C. & Cherrington, J. M., May 1 2003, In : Blood. 101, 9, p. 3597-3605 9 p.

Research output: Contribution to journalArticle

737 Scopus citations

Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit

Gazit, A., Yee, K., Uecker, A., Böhmer, F. D., Sjöblom, T., Östman, A., Waltenberger, J., Golomb, G., Banai, S., Heinrich, M. C. & Levitzki, A., May 1 2003, In : Bioorganic and Medicinal Chemistry. 11, 9, p. 2007-2018 12 p.

Research output: Contribution to journalArticle

59 Scopus citations
2002

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

Yee, K. W. H., O'Farrell, A. M., Smolich, B. D., Cherrington, J. M., McMahon, G., Wait, C. L., McGreevey, L. S., Griffith, D. J. & Heinrich, M. C., Oct 15 2002, In : Blood. 100, 8, p. 2941-2949 9 p.

Research output: Contribution to journalArticle

167 Scopus citations